CB CAR-NK019 / Zhejiang University  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CB CAR-NK019 / Zhejiang University
NCT04887012: Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

Recruiting
1
25
RoW
anti-CD19 CAR-NK, CAR-NK019
Second Affiliated Hospital, School of Medicine, Zhejiang University
B-cell Non Hodgkin Lymphoma
05/22
05/24
NCT05472558: Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

Recruiting
1
48
RoW
anti-CD19 CAR-NK, CB CAR-NK019
Second Affiliated Hospital, School of Medicine, Zhejiang University
B-cell Non Hodgkin Lymphoma
09/23
09/25
NCT06421701: Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus

Not yet recruiting
1
10
RoW
anti-CD19 CAR-NK cells
Second Affiliated Hospital, School of Medicine, Zhejiang University
Systemic Lupus Erythematosus
08/25
05/26

Download Options